首页 | 本学科首页   官方微博 | 高级检索  
检索        

IL-27对慢性丙肝患者外周血Th1/Th17水平调节作用的研究
引用本文:余晓霞,伍俊妍,丁亮,李国成.IL-27对慢性丙肝患者外周血Th1/Th17水平调节作用的研究[J].广东药学,2014(5):331-333.
作者姓名:余晓霞  伍俊妍  丁亮  李国成
作者单位:中山大学孙逸仙纪念医院药学部,广东广州510120
基金项目:广东省医院药学研究基金(编号:2013A06)
摘    要:目的探讨IL-27体外对慢性丙肝患者外周血Th1/Th17水平调节作用。方法分离慢性丙型肝炎(ChronicHepatitisC,CHC)患者和健康捐献者(HealthDonor,HD)外周血单个核细胞(Pefipheral DloodMononuclearCells,PBMC),将IL-27加入CHC患者及HD的PBMC并培养72h,CHC患者和HD外周PBMC组不做为空白对照,应用流式细胞仪检测IL-27刺激前后不同组PBMC中CD4+T细胞内IFN.1和IL-17的变化情况,计算Th1、Th17细胞比例,观察体外IL-27对CHC患者和HD外周血Th1/Th17的影响。结果IL-27刺激48h后Th1细胞亚群变化不明显,Th17细胞比例明显下降(P=0.01)。72h后CHC+IL-27组Th1细胞比例较CHC组升高(P=0.04).Th17细胞比例仍表现为下降趋势(P=0.02),变化较HD组更加明显。结论IL-27可以刺激慢性丙肝患者Th1/Th17的变化,表现为IL-27提高患者免疫系统中Th1细胞的比例,降低Th17细胞比例。

关 键 词:IL-27  慢性丙型肝炎  Th1  Th17

Effect of IL-27 on Level of Th1/Th17 in Peripheral Blood of Patients with Chronic Hepatitis C
YU Xiao-xia,WU Jun-yan,DING Liang,LI Guo-cheng.Effect of IL-27 on Level of Th1/Th17 in Peripheral Blood of Patients with Chronic Hepatitis C[J].Guangdong Pharmaceutical Journal,2014(5):331-333.
Authors:YU Xiao-xia  WU Jun-yan  DING Liang  LI Guo-cheng
Institution:( Department of Pharmacy, the Second Affiliated Hospital of Sun Yat-set University, Guangzhou, Guangdong 510120, China)
Abstract:Abstract: Objective To evaluate the effect of IL-27 on the level of Th1/Th17 in patients with chronic hepatitis C (CHC) in vitro. Methods The peripheral blood mononuclear cells (Peripheral Dlood Mononuclear Cells, PBMC ) of patients with CHC and health donor(HD) were isolated. IL-27 was added into PBMC and cultured it in vitro with PBMC alone as control. Flow cytometry was used to detect the IFN-γ, and IL-17 changes in CD4+ T cell of PBMC in each group. Then the ratio of Th1, Th2 cells were calculated, and the effect of IL-27 on Th1/Th17 in patients CHC in vitro was assessed.Results By stimulating for 48 h, IL-27 could inhibit proliferation of lymphocyte in vitro. Compared to baseline, C HC +IL-27 group did not showed a rising trend in Th 1 cell, while Th17 cells present down trend (P = 0.01 ). After 72 h, CHC+IL-27 group showed a rising trend in Th1 cell (P= 0.04) and Th17 cells still present down trend (P= 0.02) compared with that of the control group and HD group. Conclusion IL-27 played a regulatory role in Th1/Th17 in patients with CHC in vitro, by rising the ratio of Th1 cells and decreasing the Th17 cells.
Keywords:IL-27  chronic hepatitis C  Th1/Th17
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号